CIM053-ADC

N/A

Report date: 2024/01/16 17:48:05

Base Information

Drug NameCIM053-ADC
Drug Alias NameCIM053-ADCCIM-053-ADC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionLeukocyte common antigen modulators
TargetsLeukocyte common antigen
Therapy Area/IndicationsHematologic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCimeio Therapeutics AG
China Registration ClassN/A

Develop Information

Active CompaniesCimeio Therapeutics AG
Inactive CompaniesN/A
Active IndicationsHematologic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A